Skip to main content
S 3250 116th Congress Senate Crime and Law Enforcement Chemistry Crime prevention Criminal investigation, prosecution, interrogation Criminal justice information and records Customs enforcement Drug trafficking and controlled substances Government information and archives Law enforcement administration and funding

DHS Opioid Detection Resilience Act of 2020

Introduced: February 4, 2020 Introduced by: Cornyn, John Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 4, 2020
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Feb 4, 2020
Introduced in Senate
 Plain-English summary Congressional Research Service

DHS Opioid Detection Resilience Act of 2020

This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.

Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.

Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

What's happening now February 4, 2020

Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 2 Republican 2